ARQT vs HUBS · rev $235.3M vs P/E 96, rev $1.79B
Arcutis Biotherapeutics Inc (ARQT) versus HubSpot Inc (HUBS) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Latest reported ARQT revenue for 2026-06-30 was $235.3M. Net income was $3.7M. ARQT currently screens at market cap $1.64B.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
ARQT currently screens at market cap $1.64B. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Not investment advice. Open the ARQT and HUBS stock pages for the full models.
Not investment advice.